Stabilized Transdermal Drug Delivery System

Patent No. EP2299989 (titled "Stabilized Transdermal Drug Delivery System") was filed by Mylan on May 29, 2009. The application was issued on Jan 2, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
AMWOct 2, 2019BECKORD & NIEDLICH PATENTANWALTE PARTG MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2299989

MYLAN
Application Number
EP09770655A
Filing Date
May 29, 2009
Status
Opposition Rejected
Apr 2, 2022
Publication Date
Jan 2, 2019